Surgery for pathological T3a, T3b and lymph node positive prostate cancer: surgical, functional and oncological outcomes from a regional prostate cancer service
BAUS ePoster online library. Gilliland N. Jun 24, 2019; 259543; P5-13
Mr. Niall Gilliland
Mr. Niall Gilliland
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
INTRODUCTION

Surgery is increasingly employed as a treatment option for patients with high-risk prostate cancer. The present large UK contemporary study reports on the surgical, functional and oncological outcomes following surgery in these patients.

Patients and Methods
Patients with pathological T3a, T3b and N1 disease were extracted from our prospectively updated institutional database. Data includes demographics, preoperative cancer parameters, short- and long-term complications and functional results. Details of biochemical recurrence (BCR), type and oncological outcome of salvage treatments, cancer-specific (CSS) and overall survival (OS) was also obtained. Multivariate analysis was performed to determine factors for BCR post surgery and salvage treatment.

RESULTS

494 patients with complete data were obtained from with a median follow up of 4 years (range 2-10). 57%, 29% and 13% were staged as T3a, T3b and N1 respectively. Average inpatient stay was 1.7 days and overall complication rate was 11.36%. Complete continence or minor stress was seen in 82.6% and 89% reported significant ED. CSS and OS were 98.78% and 97.17 respectively. BCR was 36.71% with 82% and 39% receiving one or more than one salvage treatments respectively. Multivariate analyses demonstrate pathological stage is a predictor of BCR and immediate BCR is a predictor of failure of subsequent local salvage treatment (p<0.001).

Conclusions
Surgery is associated with encouraging surgical and functional outcomes, CSS and OS rates in these patients. Pathological stage is a significant predictor for BCR. The present analysis questions the effectiveness of further local salvage treatments in patients with an immediate BCR post operatively
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings